Subcutaneous Implantable Defibrillator

play icon
EMBLEM S-ICD provides Protection Without Touching the Heart
EMBLEM S-ICD Protects Against Sudden Cardiac Arrest
EMBLEM MRI S-ICD System Animation
EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD System)
EMBLEM MRI S-ICD System Protects Against Sudden Cardiac Arrest

Effective Defibrillation Without Transvenous Leads

EMBLEM MRI S-ICD leaves the heart and vasculature UNTOUCHED.

Key Resources


Product Details

EMBLEM MRI S-ICD?Pulse Generator Mechanical Specifications
Model Number A219
Size (W x H x D) 83.1 x 69.1 x 12.7 mm
Mass 130 g
Volume 59.5 cc (cm3)
Projected Longevity 7.3 years*
Battery Chemistry Boston Scientific Li/MnO2
Warranty 6 years**
Remote Patient Monitoring Capability Enabled for use with LATITUDE? NXT remote patient management
* Defined as 3 full-energy capacitor charges per year.
**For full warranty terms and conditions go to www.zaix4.com/en-US/pprc/warranty-info-forms.html

Clinical Information

The 2017 Guidelines by the American Heart Association (AHA), American College of Cardiology (ACC), and Heart Rhythm Society (HRS) include recommended use of the S-ICD for ICD indicated patients with1:


High Infection Risk

% of ICD Patients with Comorbidities Associated with Device Infection1

S-ICD Guidelines Chart 1

~75% of ICD Indicated Patients Have ≥1 Comorbidities Associated with Device Infection2,3,4

Inadequate Venous Access

S-ICD Guidelines Chart 2

No Pacing Indication

% of VR and DR ICD Patients Under 75 with No Pacing Indication at Implant1

S-ICD Guidelines Chart 3

Dr. Lucas Boersma Discusses the EFFORTLESS Registry 3-Year Results
EMBLEM MRI S-ICD System is the first and only subcutaneous implantable defibrillator that provides protection for patients at risk for sudden cardiac death while avoiding risks and complications associated with transvenous leads.

Ordering Information

Model Number Description
A219 EMBLEM MRI S-ICD Pulse Generator
3501 EMBLEM S-ICD Electrode
4711 EMBLEM S-ICD Electrode Insertion Tool
3200 EMBLEM S-ICD Programmer


Rhythm Management Reimbursement Resources
Follow Boston Scientific Cardiology: Twitter LinkedIn YouTube


1. Al-Khatib, SM, Stevenson, WG, Ackerman, MJ, et al., 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Heart Rhythm, 2017.

2. Polyzos, KA, Konstantelias, AA, and Falagas, ME, Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace, 2015. 17(5): p. 767-777. 

3. Greenspon, AJ, Patel, JD, Lau, E, et al., 16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States. Journal of the American College of Cardiology, 2011. 58(10): p. 1001-1006. 

4. Friedman, DJ, Parzynski, CS, Varosy, PD, et al., Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States. JAMA Cardiol, 2016. 1(8): p. 900-911.

5. Kusumoto, FM, Schoenfeld, MH, Wilkoff, BL, et al., 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm, 2017.

6 Gasparini, M, Lunati, MG, Proclemer, A, et al., Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality. JACC: Clinical Electrophysiology, 2017.

7. LATITUDE Data on File,  Boston Scientific 2017.